Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

1.41
Delayed Data
As of 3:02pm ET
 -0.035 / -2.43%
Today’s Change
1.28
Today|||52-Week Range
6.15
-19.25%
Year-to-Date
No recent news for Cyclacel Pharmaceuticals Inc.

Today’s Trading

Previous close1.44
Today’s open1.43
Day’s range1.40 - 1.44
Volume33,407
Average volume (3 months)229,567
Market cap$18.7M
Data as of 3:02pm ET, 04/24/2018

Growth & Valuation

Earnings growth (last year)+35.19%
Earnings growth (this year)+35.71%
Earnings growth (next 5 years)--
Revenue growth (last year)-56.64%
P/E ratioNM
Price/Sales21.49
Price/Book0.47

Competitors

 Today’s
change
Today’s
% change
KTOVKitov Pharma Ltd-0.02-0.85%
ACSTAcasti Pharma Inc-0.24-23.53%
HTBXHeat Biologics Inc-0.01-0.90%
DAREDare Bioscience Inc-0.01-0.91%
Data as of 3:09pm ET, 04/24/2018

Financials

Next reporting dateMay 15, 2018
EPS forecast (this quarter)--
Annual revenue (last year)$843.0K
Annual profit (last year)-$11.8M
Net profit margin-1,398.70%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Spiro Rombotis
COO, CFO, Secretary, Director &
Executive VP
Paul McBarron
Corporate headquarters
Berkeley Heights, New Jersey

Forecasts